Table 2.
THC pharmacokinetic parameters after inhalation
| Group I 10 ± 0.1 mg |
Group II 15 ± 0.1 mg |
Group III 20 ± 0.1 mg |
Group IV 25 ± 0.1 mg |
|
|---|---|---|---|---|
| Δ9-THC Cmax (ng/mL) | 35.43 ± 5.97 | 51.47 ± 13.79 | 72.37 ± 15.93 | 88.63 ± 14.75 |
| AUC0-∞ (ng min/mL) | 441.59 ± 88.49 | 624 ± 123.56 | 698.35 ± 174.98 | 971.36 ± 310.4 |
| Tmax (min) | 3.666 ± 0.471 | 3.333 ± 0.471 | 2.666 ± 0.942 | 3 ± 0.816 |
Each THC dosage group concise of four healthy volunteers. Both Δ9-THC Cmax and AUC0-∞ measured in plasma of the volunteers and calculated from the same data, are showing a linear increase in mean maximum plasma concentration of THC (Cmax) and area under the curve (AUC) both with no change in the time needed to reach such concentration
THC Cmax Tetrahydrocannabinol maximum concentration, AUC Area under the curve, Tmax time to reach maximum concentration